NASDAQ: BRLSBorealis Foods Inc Stock
$5.95+0.11 (+1.88%)
Updated May 8, 2025
BRLS Price
$5.95
Fair Value Price
N/A
Market Cap
$127.20M
52 Week Low
$3.88
52 Week High
$10.75
P/E
-4.76x
P/B
-182.79x
P/S
4.38x
PEG
N/A
Dividend Yield
N/A
Revenue
$27.67M
Earnings
-$25.33M
Gross Margin
7.9%
Operating Margin
-73.73%
Profit Margin
-91.5%
Debt to Equity
-87.23
Operating Cash Flow
-$15M
Beta
0.16
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
BRLS Overview
Oxus Acquisition Corp. is a "blank check" company formed to effect mergers, stock purchases, or similar combinations with one or more businesses. It targets companies offering energy transition technologies (battery materials, energy storage, and EV infrastructure) in emerging/frontier countries. Oxus Acquisition was incorporated in 2021 and is headquartered in Almaty, Kazakhstan.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine BRLS's potential to beat the market
- BRLS doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Food
Industry Rating
B
BRLS
RankedUnranked of 49
RankedUnranked of 49
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $11.88 | A | |
| $14.32 | A | |
| $47.30 | A |
Be the first to know about important BRLS news, forecast changes, insider trades & much more!
BRLS News
Overview
Due Diligence Score
–
Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how BRLS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
BRLS is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
BRLS is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
BRLS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more BRLS due diligence checks available for Premium users.
Valuation
BRLS fair value
Fair Value of BRLS stock based on Discounted Cash Flow (DCF)
Price
$5.95
Fair Value
-$0.59
Undervalued by
1,100.93%
BRLS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
BRLS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-4.76x
Industry
19.25x
Market
24.22x
BRLS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-182.79x
Industry
1.89x
BRLS's financial health
Profit margin
Revenue
$6.8M
Net Income
-$5.8M
Profit Margin
-85.3%
BRLS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
BRLS's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$60.0M
Liabilities
$60.7M
Debt to equity
-87.23
BRLS's short-term liabilities ($25.41M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BRLS's long-term liabilities ($35.30M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BRLS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
BRLS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$819.4k
Investing
-$198.5k
Financing
$949.3k
BRLS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
BRLS vs Food Stocks
Borealis Foods Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.